Dry Eye,Eye Exam,Eye Health,Medical News

How to Eradicate Demodex Mites
Demodex blepharitis is a common yet often overlooked condition that can significantly impact ocular health.
Demodex mites are microscopic parasites that live in the hair follicles and sebaceous glands of humans. There are two species primarily associated with ocular conditions: Demodex folliculorum and Demodex brevis. These mites can infest the eyelids, including lash follicles and sebaceous glands, leading to a condition known as Demodex blepharitis.1
Demodex blepharitis is characterized by inflammation of the eyelids, which can cause symptoms such as itching, redness, and crusting at the base of the eyelashes called collarettes. If left untreated, it can lead to more severe complications, including chronic eyelid inflammation, conjunctivitis, and keratitis. Moreover, Demodex infestation is a significant contributor to dry eye disease. The mites contributes to meibomian gland dysfunction and disrupting the tear film, thus exacerbating dry eye symptoms.
Addressing the underlying mite infestation can alleviate symptoms and improve overall ocular health.
Below are key treatment options available for Demodex Blepharitis:2
XDEMVY® (lotilaner ophthalmic solution 0.25%) is a groundbreaking, the first FDA-approved treatment for Demodex blepharitis, offering significant advantages over traditional therapies as it addresses the root cause rather than just symptoms.3
XDEMVY offers a new option for patients suffering from Demodex blepharitis. This new drug works by selectively inhibiting GABA neurotransmitter channels of Demodex mites, leading to their paralysis and death. This mechanism is highly specific and effective in eradicating mites.
Clinical trials (SATURN-1 and SATURN-2) demonstrated that XDEMVY significantly reduces collarettes, mite presence, and redness within six weeks, with many patients experiencing relief in as little as two weeks.4
While XDEMVY is widely available in the U.S., it is not yet available in Canada as it has not yet been listed in Health Canada’s Drug Product Database.
Treatment for Demodex blepharitis should be tailored to the individual based on severity and symptoms. Combining eyelid hygiene, prescription medications like XDEMVY®, and advanced in-office procedures such as ZEST and IPL ensures optimal outcomes.5 Regular follow-ups with an eye care professional are essential for monitoring progress and adjusting treatments as needed.
Please ask our doctors at North Toronto Eye Care on the Canadian availability for XDEMVY® if you have blepharitis!
References:
- Clinical diagnosis and management of Demodex blepharitis – Nature https://www.nature.com/articles/s41433-023-02500-4
- Advances in the Treatment of Demodex Blepharitis https://www.ajmc.com/view/advances-in-the-treatment-of-demodex-blepharitis-strategies-for-improving-patient-outcomes
- Tarsus announces Xdemvy availability at pharmacies nationwide https://www.optometrytimes.com/view/tarsus-announces-xdemvy-availability-at-pharmacies-nationwide
- Effectively Treating Demodex Blepharitis https://crstoday.com/articles/effectively-treating-demodex-blepharitis/effectively-treating-demodex-blepharitis-2
- Trends in the Management of Demodex Blepharitis Highlight the … https://www.jmcp.org/pb-assets/Outserts/23164%20-%20Tarsus_JMCP_Paper_Spotlight.FINAL-1696953438710.pdf